Parvovirus B19 Antibody, IgM
HLA DQ Genotyping for Celiac Disease
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Erythrocyte Sedimentation Rate (ESR)
Severe Combined Immunodeficiency Gene Panel, NGS
Avantect Pancreatic Cancer Test
Creatinine, Serum
Biopsy, Colon
Spinocerebellar Ataxia Type 3 (SCA3) (Machado-Joseph Disease) Gene Mutation Analysis
Amikacin, Random, Serum
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Additional ICD10
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now